Dr. Jessica Lichter, Assistant Professor and academic hospitalist at Elmhurst Hospital, part of the New York City Health + ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to ...

Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...

Researchers developed iDOMO, an AI-powered computational tool that predicts synergistic drug combinations using gene ...

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

In honor of American Heart Month, Healio Dermatology interviewed experts and explored the connection between skin disease and heart health.The discovery of this relationship can be traced back to ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of ...

Among patients with pulmonary arterial hypertension treated with 72-week seralutinib, those deemed responders had more ...

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that ...

Gregg Stone cast doubt on its reliability in trials, while David Cohen said QoL matters to patients and should be measured.

People who can exercise sufficiently on a treadmill during cardiac stress testing have a lower mortality risk regardless of ...

Health systems are beginning to hire chiefs of artificial intelligence and other AI leaders to bring new expertise into the system with the goal of becoming a more sophisticated, data-driven ...